濮阳市东方医院可靠(濮阳东方医院男科看阳痿非常便宜) (今日更新中)

PARIS, Oct. 15 (Xinhua) -- Faced with new problems such as sovereign debt and downward risks, all countries should work together to enhance coordination on macroeconomic policies to guard economic growth and financial stability with respective effort, Chinese delegates said Saturday here at the G20 Financial Ministers Meeting.The global economy is challenged by new difficulties which require all countries to join hands in fighting all sorts of protectionism either in trade or in investment, according to a statement issued by the Chinese delegation led by Chinese Financial Minister Xie Xuren and Central Bank Governor Zhou Xiaochuan.China suggested that leading developed countries should ensure economic recovery and financial stability in short term, while in the medium term enhance fiscal solidarity, accelerate structural reform and refrain the negative impact of macroeconomic policies.Meanwhile, China also stressed that the emerging countries should make their own contribution to tackle the problems. "The emerging markets should promptly take flexible and effective macroeconomic measures in order to control slowdown and tackle with impacts from inflation and capital flows," the statement said.Emerging economies "should also quicken their pace on structural reform in a bid to realize stable and faster growth," the statement added.During the two-day meeting, G20 financial leaders gathering in Paris welcomed the progress the Europe made on the eurozone debt issue on Saturday, but meanwhile expected the euro area to rely more on itself with bigger bailout fund to avoid contagion.

WASHINGTON, Dec. 16 (Xinhua) -- The U.S. International Trade Commission (USITC) Friday launched a probe into certain products from China after several U.S. companies alleged their patents were infringed.The products in question include televisions and Blu-ray players produced by Haier Group of China and Vizio Inc. under Taiwan-based Amtran Technology Company and sold in the U.S. market, the USITC said.` Five U.S. technology companies filed a complaint with USITC last month, saying those products violated Section 337 of the Tariff Act of 1930 by infringing their patents.Meanwhile, they requested the USITC issue an exclusion order and a cease and desist order against those products from China.The trade panel is scheduled to set a target date for completing the investigation within 45 days after institution of the probe. If the complaint is approved, the agency will ban importation of those products.The U.S. move came at a time when protectionism is making a comeback in the United States amid sluggish economic recovery.It is widely believed that such actions would only hurt U.S.- China trade relations that are increasingly critical to global economic recovery.

SUVA, Oct. 3 (Xinhua) -- It is Pinktober again and Fiji like the rest of the world will be raising awareness of breast cancer too, Fiji Cancer Society Chairperson and breast cancer awareness month President Nirmala Nambiar has said."Join the fight against breast cancer through early detection and awareness." This is the message the Fiji Cancer Society is sending out this October, which is breast cancer awareness month, worldwide.Fiji Cancer Society Chairperson and breast cancer awareness month President Nirmala Nambiar said, "Fiji continues to have a high incidence of breast cancer deaths with large number of tumors presented to health professionals at a late stage due to the stigma of having the disease."In the first quarter of 2011, there were 46 new breast cancer cases recorded, whilst there were 33 new cases in the same period last year."The figures could be scary but one must understand that as the awareness increases in our communities the number of cases recorded increases," she warned.Men and women should be aware that age, obesity and family history are all factors that contribute to the risk of developing the disease.This October the Fiji Cancer Society has planned a number of events all targeted to raise awareness since the lack of information and education is dangerous.Nambiar said through partnership with the Ministry of Health, Oxfam Clinic in Suva and the Fiji Nurses Association, supported by the sponsorship of Colgate Palmolive, the focus this year is on reaching out to the rural community and making a difference to the lives of the poor and unprivileged."We have free checkups planned for the month at the major villages from Vunidawa, Korovou and Valelevu to Lami at the other end and hope that we will be able to support the women in this area who may not be able to have a check- up otherwise.According to the official, the society's western branch continues to arrange free check- ups with the support of the Patan Clinic.The awareness and free checkups have also been arranged for corporate organizations at their request and if we are not able to provide all this during October we will continue to schedule them for the following month.The Society's thanks go to Suva Private Hospital for offering half price mammograms for the month of October, Nambiar said, adding a common issue with Fiji women, according to doctors at the hospital, was the return rate."Once they hear the news that they have cancer, many women don' t return because of the fear of what's next. Hence the Society is working with the hospitals and helping counsel patients to get them back for treatment rather than fight the losing battle, since 70 percent of cancer cases can be saved through early detection and treatment," she said.The Fiji Cancer Society strongly believes that the success of the awareness program this month will set the platform for the society's ongoing initiative to drive and raise the community's understanding, get them involved and make them take care of each other. 

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

BEIJING, Jan. 10 (Xinhua) -- Chinese State Councilor Dai Bingguo on Tuesday attended a reception at the Great Hall of People in Beijing celebrating the 20th anniversary of the establishment of diplomatic ties between China and five Central Asian countries.China successively established diplomatic relations with Uzbekistan, Kazakhstan, Kyrgyzstan, Tajikistan and Turkmenistan in early January of 1992.In his address, Dai said relations between China and the five nations have achieved comprehensive and significant progress since they forged diplomatic ties 20 years ago, featuring frequent high-level visits, deepened political mutual trust, mutual support on major issues of each other's concern and expanded mutually beneficial cooperation in various fields.China and the five countries have maintained close coordination within the framework of the United Nations and the Shanghai Cooperation Organization and have positively contributed to safeguarding and promoting the world's peace, stability and development, he said.Noting China and the Central Asian nations are good neighbors, good friends and good partners, Dai said, no matter how the international situation changes, China will adhere to the policy of building friendship and partnership with its neighbors and support the five nations to independently choose their development path.China will unswervingly advance traditional friendship and cooperation with the five nations and will work with them to make unremitting efforts for building a harmonious world of lasting peace and common prosperity, he said.Dai said China will take the opportunity of celebrating the 20th anniversary to increase political mutual trust, expand mutually beneficial cooperation and develop traditional friendship with the five nations, in the hope of jointly creating a bright future for their relations.Li Xiaolin, president of the Chinese People's Association for Friendship with Foreign Countries, and diplomatic envoys from the five Central Asian nations also addressed the reception.

来源：资阳报